Sofituzumab vedotin Antibody
Sofituzumab vedotin (DMUC5754A) is an antibody-drug conjugate (ADC) targeting MUC16 and delivering the cytotoxic agent MMAE via a cleavable linker. It is used in cancer research for investigating ADC mechanisms and efficacy in both in vitro cell-based assays and in vivo tumor models.
Product Specifications
Target
Mucin, Antibody-Drug Conjugates (ADCs)
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog